Pharmacology of restless legs syndrome (RLS)
Author(s)
Bibliographic Information
Pharmacology of restless legs syndrome (RLS)
(Advances in pharmacology / edited by Silvio Garattini [and] Parkhurst A. Shore, v. 84)
Academic Press, 2019
- hbk.
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Serial editor: S.J. Enna, Lynn Lecount
Description and Table of Contents
Description
Pharmacology of Restless Legs Syndrome (RLS), Volume 84, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field on essential topics, with this volume presenting chapters on Targeting the adenosinergic system in Restless Legs Syndrome, Assessing iron uptake mechanisms in the brain: impact of gender and genotype, Pharmacological treatments of RLS in augmentation, C. elegans and its applicability to studies on RLS, The neurophysiology of hyperarousal in RLS: hints for a role of glutamate/GABA, Treatment management and options in RLS patients, Pharmacological responsiveness of Periodic Legs Movements during Sleep, and more.
Table of Contents
1. Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport Sergi Ferre, Cesar Quiroz, William Rea, Xavier Guitart and Diego Garcia-Borreguero 2. D3 receptor agonist efficacy in restless legs syndrome Francesca Casoni, Andrea Galbiati and Luigi Ferini-Strambi 3. The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome Antoni Cortes, Veronica Casado-Anguera, Estefania Moreno and Vicent Casado 4. D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics Stefan Clemens and Imad Ghorayeb 5. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA Giuseppe Lanza and Raffale Ferri 6. Iron uptake at the blood-brain barrier is influenced by sex and genotype Quinn W. Wade, Brian Chiou and James R. Connor 7. Caenorhabditis elegans and its applicability to studies on restless legs syndrome Pan Chen, Omamuyovwi Meashack Ijomone, Kun He Lee and Michael Aschner 8. Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice Aaro V. Salminen, Daniel D. Lam and Juliane Winkelmann 9. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome Vivian Wanner, Celia Garcia Malo, Sofia Romero, Irene Cano-Pumarega and Diego Garcia-Borreguero 10. Idiopathic restless legs syndrome treatment: Progress and pitfalls? Imad Ghorayeb 11. Treatment of pediatric restless legs syndrome Lourdes DelRosso and Oliviero Bruni 12. Pharmacological treatments of augmentation in restless legs syndrome patients Claudia Trenkwalder and Walter Paulus
by "Nielsen BookData"